Mitchell P. Kopin 13D and 13G filings for ASLAN Pharmaceuticals Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-03-21 4:42 pm Purchase | 2024-03-12 | 13G | ASLAN Pharmaceuticals Limited ASLN | Mitchell P. Kopin | 3,125,000 4.400% | 3,125,000 (New Position) | Filing |